ProfileGDS5822 / ILMN_2510152
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 2% 7% 22% 5% 22% 8% 20% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 162
GSM1276600PDAC Late Ablation Control 210.77
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.822
GSM1276603PDAC Late Ablation 265
GSM1276604PDAC Late Ablation 312.722
GSM1303940PDAC Late Ablation_anti-CTLA4 18.58
GSM1303941PDAC Late Ablation_anti-CTLA4 210.820
GSM1303942PDAC Late Ablation_anti-CTLA4 39.918